Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients

Patients with normal karyotype represent the single largest cytogenetic group of acute myeloid leukemia (AML), with highly heterogeneous clinical and molecular characteristics. In this study, we sought to determine new prognostic biomarkers in cytogenetically normal (CN)-AML patients. A gene express...

Descripción completa

Detalles Bibliográficos
Autores principales: Bou Samra, Elias, Klein, Bernard, Commes, Thérèse, Moreaux, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478459/
https://www.ncbi.nlm.nih.gov/pubmed/22910040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478459/
https://www.ncbi.nlm.nih.gov/pubmed/22910040

Ejemplares similares